Rio de Janeiro, Brazil

Carlos Alberto Manssour Fraga

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: University System of Maryland. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Alberto Manssour Fraga. Retrieved from https://idiyas.com/inventor/carlos-alberto-manssour-fraga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Carlos Alberto Manssour Fraga

Introduction

Carlos Alberto Manssour Fraga is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with therapeutic properties. His work focuses on creating innovative solutions for medical challenges, especially in treating heart conditions.

Latest Patents

Fraga holds a patent for a compound known as Thienylhydrazon, which exhibits digitalis-like properties. This invention is particularly noteworthy for its positive inotropic effects, which enhance the strength of heart contractions. The compound is characterized by a specific formula where R is selected from hydrogen, alkyl groups of 1 to 6 carbon atoms, unsubstituted phenyl, and substituted phenyl. Additionally, the invention includes a novel method for synthesizing 3,4-methylenedioxybenzoyl-2-thienylhydrazone, also referred to as LASSBio-294. This compound is beneficial for treating congestive heart failure and muscle fatigue, while lacking the toxic effects commonly associated with digitalis glycosides.

Career Highlights

Fraga is affiliated with the University System of Maryland, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in the field of medicinal chemistry. His innovative approach to drug development has garnered attention and respect within the scientific community.

Collaborations

Throughout his career, Fraga has collaborated with esteemed colleagues, including Roberto Takashi Sudo and Edson X Albuquerque. These partnerships have facilitated the exchange of ideas and advancements in their shared field of research.

Conclusion

Carlos Alberto Manssour Fraga's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for heart-related conditions. His work exemplifies the potential of scientific inquiry to improve health outcomes and advance medical knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…